This is a routine, small-value Form 144 filed by a director following a vesting event. The dollar amount is negligible relative to the company's market cap, and the insider is not CEO/CFO. No trading signal is warranted; monitor for any subsequent Form 4 filings to confirm whether the sale was executed.
XNCR drugs
XNCR drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 15 $12.21entry
- T+1 · 5mo ago −0.08%α +0.51% · $12.20
- T+5 · 5mo ago +14.74%α +16.13% · $14.01
- T+20 · 4mo ago +22.52%α +23.27% · $14.96
- T+60 · 2mo ago +104.26%α +103.26% · $24.94
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Richard J. Ranieri filed a Form 144 to sell 5,474 shares of Xencor Inc (XNCR) worth approximately $68,385, acquired via restricted stock vesting on June 12, 2026. This intent-to-sell notice is a small, routine transaction relative to the company's $914M market cap, and the insider remains a director. No material change in business outlook is implied.
Key Facts
- Director Richard J. Ranieri filed a Form 144 to sell 5,474 shares of common stock.
- The shares were acquired through restricted stock vesting on June 12, 2026.
- Estimated sale proceeds are approximately $68,385 (based on market price).
- Sale is intended for June 15, 2026, on the Nasdaq exchange.
- The insider is a director, not executive management, reducing signaling significance.
- Proceeds are small relative to the company's $914M market cap (~0.0075% of market cap).
Financial Impact
Proposed sale of 5,474 shares valued at ~$68,385, immaterial relative to the company's $914M market capitalization.
Risk Factors
- No material risk identified from this filing.
- Broader biotech sector risks and clinical-stage pipeline setbacks are the primary risks to XNCR shareholders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-004634 |
| Document: 0001959173-26-004634-index.html | 0001959173-26-004634 |
| Document: 0001959173-26-004634.txt | 0001959173-26-004634 |
Track record
20 reports on XNCR
4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +67.24% at T+60 after the May 5, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $35.40 Now $35.40 +0.00% settles Nov 18
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $39.23 Now $35.40 −9.77% settles Nov 17
- Nov 12, 20264d ago Insider Cluster Neutral 4/10 Entry $37.09 to $35.40 Now $35.40 −4.56% ▼ −4.56% −2.65% vs SPY
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $38.13 to $37.09 Now $35.40 −7.16% ▼ −2.73% −2.36% vs SPY
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $39.97 to $38.13 Now $35.40 −11.43% ▼ −4.60% −4.25% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $35.75 to $38.59 Now $35.40 −0.98% ▲ +7.94% +5.58% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $34.05 to $35.75 Now $35.40 +3.96% ▲ +4.99% +4.68% vs SPY
- Oct 30, 202617d ago SC 13G/A Bearish 4/10 Entry $29.82 to $29.66 Now $35.40 −18.71% ▲ +0.54% +0.06% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $29.99 to $29.21 Now $35.40 +18.04% ▼ −2.60% −2.22% vs SPY
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $29.18 to $29.99 Now $35.40 +21.32% ▲ +2.78% +2.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers